These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33094717)

  • 1. SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020.
    Lumley SF; Eyre DW; McNaughton AL; Howarth A; Hoosdally S; Hatch SB; Kavanagh J; Chau KK; Downs LO; Cox S; Dunn L; Justice A; Wareing S; Dingle K; Rudkin J; Auckland K; Fyfe A; Bolton J; Paton R; Mentzer AJ; Jeffery K; Andersson MI; James T; Peto TEA; Marsden BD; Screaton G; Cornall RJ; Klenerman P; Ebner D; Stuart DI; Crook DW; Stoesser N; Kennedy SH; Thompson C; Gupta S; Matthews PC
    Euro Surveill; 2020 Oct; 25(42):. PubMed ID: 33094717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.
    Thompson CP; Grayson NE; Paton RS; Bolton JS; Lourenço J; Penman BS; Lee LN; Odon V; Mongkolsapaya J; Chinnakannan S; Dejnirattisai W; Edmans M; Fyfe A; Imlach C; Kooblall K; Lim N; Liu C; López-Camacho C; McInally C; McNaughton AL; Ramamurthy N; Ratcliff J; Supasa P; Sampson O; Wang B; Mentzer AJ; Turner M; Semple MG; Baillie K; ; Harvala H; Screaton GR; Temperton N; Klenerman P; Jarvis LM; Gupta S; Simmonds P
    Euro Surveill; 2020 Oct; 25(42):. PubMed ID: 33094713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seroprevalence among parturient women in Philadelphia.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Gerber JS; Arevalo CP; Bolton MJ; Weirick ME; Goodwin EC; Anderson EM; Greenplate AR; Kim J; Han N; Pattekar A; Dougherty J; Kuthuru O; Mathew D; Baxter AE; Vella LA; Weaver J; Verma A; Leite R; Morris JS; Rader DJ; Elovitz MA; Wherry EJ; Puopolo KM; Hensley SE
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32727884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
    Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
    Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
    JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
    Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
    Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT).
    Meyer B; Reimerink J; Torriani G; Brouwer F; Godeke GJ; Yerly S; Hoogerwerf M; Vuilleumier N; Kaiser L; Eckerle I; Reusken C
    Emerg Microbes Infect; 2020 Dec; 9(1):2394-2403. PubMed ID: 33043818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
    J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
    Ng DL; Goldgof GM; Shy BR; Levine AG; Balcerek J; Bapat SP; Prostko J; Rodgers M; Coller K; Pearce S; Franz S; Du L; Stone M; Pillai SK; Sotomayor-Gonzalez A; Servellita V; Martin CSS; Granados A; Glasner DR; Han LM; Truong K; Akagi N; Nguyen DN; Neumann NM; Qazi D; Hsu E; Gu W; Santos YA; Custer B; Green V; Williamson P; Hills NK; Lu CM; Whitman JD; Stramer SL; Wang C; Reyes K; Hakim JMC; Sujishi K; Alazzeh F; Pham L; Thornborrow E; Oon CY; Miller S; Kurtz T; Simmons G; Hackett J; Busch MP; Chiu CY
    Nat Commun; 2020 Sep; 11(1):4698. PubMed ID: 32943630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
    Lin Q; Zhu L; Ni Z; Meng H; You L
    J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.
    Fischer B; Knabbe C; Vollmer T
    Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.
    Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL;
    Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
    Bryan A; Pepper G; Wener MH; Fink SL; Morishima C; Chaudhary A; Jerome KR; Mathias PC; Greninger AL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.
    Song SK; Lee DH; Nam JH; Kim KT; Do JS; Kang DW; Kim SG; Cho MR
    J Korean Med Sci; 2020 Jul; 35(29):e269. PubMed ID: 32715672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
    Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
    Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serological survey of SARS-CoV-2 in cat in Wuhan.
    Zhang Q; Zhang H; Gao J; Huang K; Yang Y; Hui X; He X; Li C; Gong W; Zhang Y; Zhao Y; Peng C; Gao X; Chen H; Zou Z; Shi ZL; Jin M
    Emerg Microbes Infect; 2020 Dec; 9(1):2013-2019. PubMed ID: 32867625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.